Northern Trust’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $751K | Sell |
82,779
-1,854
| -2% | -$16.8K | ﹤0.01% | 3517 |
|
2025
Q1 | $807K | Sell |
84,633
-2,790
| -3% | -$26.6K | ﹤0.01% | 3371 |
|
2024
Q4 | $982K | Buy |
87,423
+12,923
| +17% | +$145K | ﹤0.01% | 3401 |
|
2024
Q3 | $1.07M | Buy |
74,500
+50,180
| +206% | +$721K | ﹤0.01% | 3333 |
|
2024
Q2 | $420K | Buy |
24,320
+3,105
| +15% | +$53.6K | ﹤0.01% | 3572 |
|
2024
Q1 | $423K | Buy |
21,215
+232
| +1% | +$4.63K | ﹤0.01% | 3616 |
|
2023
Q4 | $221K | Buy |
+20,983
| New | +$221K | ﹤0.01% | 3869 |
|
2022
Q2 | – | Sell |
-35,060
| Closed | -$688K | – | 4772 |
|
2022
Q1 | $688K | Sell |
35,060
-1,582
| -4% | -$31K | ﹤0.01% | 3603 |
|
2021
Q4 | $891K | Buy |
36,642
+132
| +0.4% | +$3.21K | ﹤0.01% | 3589 |
|
2021
Q3 | $1.43M | Buy |
36,510
+24,412
| +202% | +$954K | ﹤0.01% | 3422 |
|
2021
Q2 | $544K | Buy |
+12,098
| New | +$544K | ﹤0.01% | 3680 |
|